BDBM297882 3-(3-ethyl-1,2,4- oxadiazol-5-yl)-7- (piperidin-4- yl)pyrazolo[1,5- a]pyrimidin-5(4H)-one::US10118930, Example 107::US10118930, Example 199

SMILES CCc1noc(n1)-c1cnn2c(cc(=O)[nH]c12)C1CCNCC1

InChI Key InChIKey=RHEMDTHEFXFTFX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 297882   

TargetTissue-type plasminogen activator(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM297882(US10118930, Example 107 | 3-(3-ethyl-1,2,4- oxadia...)
Affinity DataIC50: 34nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent

TargetTissue-type plasminogen activator(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM297882(US10118930, Example 107 | 3-(3-ethyl-1,2,4- oxadia...)
Affinity DataIC50: 49nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent